Prescription Drugs

Prescription drugs save lives, but unsafe medications can cause devastating harm. We report on FDA warnings, recalls, and lawsuits tied to dangerous drugs. Our coverage explores how regulations, litigation, and patient advocacy drive accountability and improve medication safety.

Depo-Provera Birth Control Linked to Brain Tumors

Recent studies have raised serious concerns about the safety of Depo-Provera birth control, particularly regarding its potential link to brain tumors.

By Childers, Schlueter & Smith

/ 6 Mar 2025

Depo-Provera Birth Control Linked to Brain Tumors

Does Thyroid Eye Disease Drug Tepezza Cause Hearing Loss?

Some studies have shown that Tepezza, a new prescription infusion medication for thyroid eye disease, has some serious side effects. Patients have experienced subjective hearing symptoms.

By Childers, Schlueter & Smith

/ 13 Jun 2023

Does Thyroid Eye Disease Drug Tepezza Cause Hearing Loss?

First Tepezza Lawsuit Filed in Georgia

Childers, Schlueter & Smith has filed the first lawsuit in Georgia against the manufacturers of Tepezza, the first FDA-approved thyroid eye disease (TED) drug.

By Childers, Schlueter & Smith

/ 29 Mar 2023

From Heartburn to Cancer: What To Know If You Took Zantac

It has been six months since the Food and Drug Administration (FDA) ordered retailers to stop selling all prescription and over-the-counter (OTC) ranitidine medications, commonly known as Zantac.

By Childers, Schlueter & Smith

/ 29 Sep 2020

From Heartburn to Cancer: What To Know If You Took Zantac

Popular Heartburn Drug Zantac Pulled From The Market

After a thorough investigation, the U.S. Food and Drug Administration (FDA) has requested that manufacturers immediately withdraw all prescription and over-the-counter (OTC) ranitidine medications, commonly known by the brand name Zantac, from the market.

By Andy Childers

/ 15 Apr 2020

Popular Heartburn Drug Zantac Pulled From The Market

Weight Loss Drug Belviq Pulled From Market Due to Potential Cancer Risk

Promising weight-loss drug Belviq has been pulled off the U.S. market due to the potential risk of cancer. At the request of the U.S. Food and Drug Administration (FDA), drug manufacturer Eisai Inc. has voluntarily withdrawn and discontinued sales of Belviq (lorcaserin). The FDA took…

By M. Brandon Smith

/ 9 Mar 2020

Weight Loss Drug Belviq Pulled From Market Due to Potential Cancer Risk

More Ranitidine (Zantac) Recalls Issued Over Possible Carcinogen NDMA

On Nov. 4, I blogged about the Food & Drug Administration’s (FDA’s) public statement announcing the detection of N-nitrosodimethylamine (NDMA) in preliminary tests of the heartburn medication ranitidine, which is most often sold under the brand name Zantac. NDMA is a chemical agent categorized as…

By M. Brandon Smith

/ 13 Nov 2019

More Ranitidine (Zantac) Recalls Issued Over Possible Carcinogen NDMA

Zantac Heartburn Medication Recalled After Detection of Cancer-causing Chemical NDMA

On Sep. 13, the Food & Drug Administration (FDA) issued a public statement announcing that low levels of N-nitrosodimethylamine (NDMA) were detected in preliminary tests of the popular heartburn medication ranitidine, which is most often sold under the brand name Zantac. NDMA is a chemical…

By M. Brandon Smith

/ 4 Nov 2019

Zantac Heartburn Medication Recalled After Detection of Cancer-causing Chemical NDMA

Health, Environmental, and Farmer Groups Call for EPA to Remove Glyphosate Products from U.S. Market

On Sep. 3, 2019 Sixteen (16) health, environmental, farmer, and farmworker organizations released a joint statement calling for the Environmental Protection Agency (EPA) to remove glyphosate from the U.S. marketplace due to an abundance of evidence linking it to a type of cancer called non-Hodgkin’s

By M. Brandon Smith

/ 6 Sep 2019

Health, Environmental, and Farmer Groups Call for EPA to Remove Glyphosate Products from U.S. Market

New Appeals Court Filing: Lawyers Call for Jury-awarded Punitive Damages to be Upheld in Roundup Cancer Verdict

On Aug. 10, 2018, a California state jury unanimously found that Monsanto’s glyphosate-based Roundup weed killer caused plaintiff Dewayne “Lee” Johnson to develop a type of cancer called non-Hodgkin’s lymphoma (NHL). The jury also found that Monsanto failed to appropriately warn Roundup users of thi

By M. Brandon Smith

/ 22 Aug 2019

New Appeals Court Filing: Lawyers Call for Jury-awarded Punitive Damages to be Upheld in Roundup Cancer Verdict

U.S. Judge Plans to Reduce Award in Roundup Cancer Lawsuit

On July 18, 2019 a California judge announced a tentative ruling saying she will reduce the $2 billion award against Bayer AG, which was awarded to a couple who both developed NHL cancer after using Bayer’s glyphosate-based weed killer Roundup on their properties for decades.…

By M. Brandon Smith

/ 23 Jul 2019

U.S. Judge Plans to Reduce Award in Roundup Cancer Lawsuit

Is Bayer Heading Towards a Settlement for Roundup Cancer Lawsuits?

On June 26, Bayer AG announced new steps it is taking to resolve the thousands of lawsuits linked to Monsanto’s glyphosate-based weed killer Roundup. Today there are over 14,000 pending lawsuits against Bayer-owned Monsanto alleging Roundup caused heavily exposed users cancer. More specifically, the

By M. Brandon Smith

/ 11 Jul 2019

Is Bayer Heading Towards a Settlement for Roundup Cancer Lawsuits?